Search Results 591-600 of 14834 for anti-TNF drugs

  1. Nalbuphine (Injection Route) Description and Brand Names - Mayo Clinic

    Nalbuphine belongs to the group of medicines called narcotic analgesics (pain medicines). It acts on the central nervous system (CNS) to relieve pain.

  2. Lovotibeglogene Autotemcel (Intravenous Route) Description and Brand Names - Mayo Clinic

    Lovotibeglogene autotemcel injection is a one-time gene therapy used to treat sickle cell disease (red blood cell disease) in patients who have a history of ...

  3. Use of MRI and PET for Assessing Disease Activity in Takayasu's Arteritis - Mayo Clinic

    ... (TNF) is important in the formation of granulomas. In this study, we assessed therapy with anti-TNF agents in patients with TA that was not controlled by ...

  4. Antithyroid Agent (Oral Route, Rectal Route) Before Using - Mayo Clinic

    If you are taking a large dose, it may be necessary for you to stop breast-feeding during treatment. Drug Interactions. Although certain medicines should not be ...

  5. A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030) - Mayo Clinic

    Current treatment with anti-viral therapy for HBV. Treatment with investigational therapy within 42 days prior to initiation of study treatment ... TNF-α ...

  6. Antihemophilic Factor Viii And Von Willebrand Factor (Intravenous Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  7. Bevacizumab with or without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients with Recurrent Glioblastoma Multiforme - Mayo Clinic

    Giving anti-endoglin monoclonal antibody TRC105 together with bevacizumab may be an effective treatment for glioblastoma multiforme. Participation eligibility.

  8. CAR-T Cell Therapy Program

    Mayo Clinic's CAR-T Cell Therapy Program offers a new cancer immunotherapy that involves genetically modifying T cells to activate the immune system to ...

  9. Beta-Adrenergic Blocker (Ophthalmic Route) Before Using - Mayo Clinic

    Ophthalmic beta-adrenergic blocking agents may be absorbed into the body. These medicines have not been studied in pregnant women. Studies in animals have not ...

  10. AI Modeling for Therapeutic Drugs: Discovery to Design to Development - Drug Discovery, Design and Optimization for Novel Therapeutics: Thomas Caulfield - Mayo Clinic Research

    Dr. Caulfield and his colleagues at Mayo Clinic use artificial intelligence algorithms and deep learning frameworks to curate and pre-process datasets of ...